Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, and further to its letter dated 02nd June 2022 regarding intimation of Investors/ Analyst conference call held on today, 06th June, 2022, on the Audited Financial Results of the Company for the fourth quarter and financial year ended 31st March, 2022, SMS Pharmaceuticals has informed that the audio recording of the said call has been uploaded on the Company’s website. This can be accessed via the following link. https://smspharma.com/wp-content/uploads/2022/06/Q4FY22-Concall-AudioTranscript.mp3.
The above information is a part of company’s filings submitted to BSE.
